185 related articles for article (PubMed ID: 19146426)
1. Residual structure in islet amyloid polypeptide mediates its interactions with soluble insulin.
Wei L; Jiang P; Yau YH; Summer H; Shochat SG; Mu Y; Pervushin K
Biochemistry; 2009 Mar; 48(11):2368-76. PubMed ID: 19146426
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic beta-cell granule peptides form heteromolecular complexes which inhibit islet amyloid polypeptide fibril formation.
Jaikaran ET; Nilsson MR; Clark A
Biochem J; 2004 Feb; 377(Pt 3):709-16. PubMed ID: 14565847
[TBL] [Abstract][Full Text] [Related]
3. Suppression of IAPP fibrillation at anionic lipid membranes via IAPP-derived amyloid inhibitors and insulin.
Sellin D; Yan LM; Kapurniotu A; Winter R
Biophys Chem; 2010 Aug; 150(1-3):73-9. PubMed ID: 20153100
[TBL] [Abstract][Full Text] [Related]
4. Destabilization of human IAPP amyloid fibrils by proline mutations outside of the putative amyloidogenic domain: is there a critical amyloidogenic domain in human IAPP?
Abedini A; Raleigh DP
J Mol Biol; 2006 Jan; 355(2):274-81. PubMed ID: 16303136
[TBL] [Abstract][Full Text] [Related]
5. pH-Dependent interactions of human islet amyloid polypeptide segments with insulin studied by replica exchange molecular dynamics simulations.
Jiang P; Wei L; Pervushin K; Mu Y
J Phys Chem B; 2010 Aug; 114(31):10176-83. PubMed ID: 20684641
[TBL] [Abstract][Full Text] [Related]
6. Islet amyloid polypeptide: mechanisms of amyloidogenesis in the pancreatic islets and potential roles in diabetes mellitus.
Johnson KH; O'Brien TD; Betsholtz C; Westermark P
Lab Invest; 1992 May; 66(5):522-35. PubMed ID: 1573849
[TBL] [Abstract][Full Text] [Related]
7. Environmental factors differently affect human and rat IAPP: conformational preferences and membrane interactions of IAPP17-29 peptide derivatives.
Pappalardo G; Milardi D; Magrì A; Attanasio F; Impellizzeri G; La Rosa C; Grasso D; Rizzarelli E
Chemistry; 2007; 13(36):10204-15. PubMed ID: 17902185
[TBL] [Abstract][Full Text] [Related]
8. Membrane permeabilization by Islet Amyloid Polypeptide.
Engel MF
Chem Phys Lipids; 2009 Jul; 160(1):1-10. PubMed ID: 19501206
[TBL] [Abstract][Full Text] [Related]
9. The role of His-18 in amyloid formation by human islet amyloid polypeptide.
Abedini A; Raleigh DP
Biochemistry; 2005 Dec; 44(49):16284-91. PubMed ID: 16331989
[TBL] [Abstract][Full Text] [Related]
10. Structure-based design and study of non-amyloidogenic, double N-methylated IAPP amyloid core sequences as inhibitors of IAPP amyloid formation and cytotoxicity.
Kapurniotu A; Schmauder A; Tenidis K
J Mol Biol; 2002 Jan; 315(3):339-50. PubMed ID: 11786016
[TBL] [Abstract][Full Text] [Related]
11. Islet pathology of non-insulin-dependent diabetes mellitus (NIDDM).
Westermark P
Diabet Med; 1996 Sep; 13(9 Suppl 6):S46-8. PubMed ID: 8894481
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the heparin binding site in the N-terminus of human pro-islet amyloid polypeptide: implications for amyloid formation.
Abedini A; Tracz SM; Cho JH; Raleigh DP
Biochemistry; 2006 Aug; 45(30):9228-37. PubMed ID: 16866369
[TBL] [Abstract][Full Text] [Related]
13. Identification of a novel human islet amyloid polypeptide beta-sheet domain and factors influencing fibrillogenesis.
Jaikaran ET; Higham CE; Serpell LC; Zurdo J; Gross M; Clark A; Fraser PE
J Mol Biol; 2001 May; 308(3):515-25. PubMed ID: 11327784
[TBL] [Abstract][Full Text] [Related]
14. Toxic human islet amyloid polypeptide (h-IAPP) oligomers are intracellular, and vaccination to induce anti-toxic oligomer antibodies does not prevent h-IAPP-induced beta-cell apoptosis in h-IAPP transgenic mice.
Lin CY; Gurlo T; Kayed R; Butler AE; Haataja L; Glabe CG; Butler PC
Diabetes; 2007 May; 56(5):1324-32. PubMed ID: 17353506
[TBL] [Abstract][Full Text] [Related]
15. Islet amyloid polypeptide in proliferating pancreatic B cells during development, hyperplasia, and neoplasia in humans and mice.
Rindi G; Terenghi G; Westermark G; Westermark P; Moscoso G; Polak JM
Am J Pathol; 1991 Jun; 138(6):1321-34. PubMed ID: 1647136
[TBL] [Abstract][Full Text] [Related]
16. Amyloidogenicity and cytotoxicity of islet amyloid polypeptide.
Kapurniotu A
Biopolymers; 2001; 60(6):438-59. PubMed ID: 12209476
[TBL] [Abstract][Full Text] [Related]
17. Lipid membranes modulate the structure of islet amyloid polypeptide.
Jayasinghe SA; Langen R
Biochemistry; 2005 Sep; 44(36):12113-9. PubMed ID: 16142909
[TBL] [Abstract][Full Text] [Related]
18. Insulin, islet amyloid polypeptide and C-peptide interactions evaluated by mass spectrometric analysis.
Landreh M; Alvelius G; Johansson J; Jörnvall H
Rapid Commun Mass Spectrom; 2014 Jan; 28(2):178-84. PubMed ID: 24338965
[TBL] [Abstract][Full Text] [Related]
19. Identification of a penta- and hexapeptide of islet amyloid polypeptide (IAPP) with amyloidogenic and cytotoxic properties.
Tenidis K; Waldner M; Bernhagen J; Fischle W; Bergmann M; Weber M; Merkle ML; Voelter W; Brunner H; Kapurniotu A
J Mol Biol; 2000 Jan; 295(4):1055-71. PubMed ID: 10656810
[TBL] [Abstract][Full Text] [Related]
20. Effect of pressure on islet amyloid polypeptide aggregation: revealing the polymorphic nature of the fibrillation process.
Radovan D; Smirnovas V; Winter R
Biochemistry; 2008 Jun; 47(24):6352-60. PubMed ID: 18498175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
